Evidence map›Paper›PMID 28746337›Full record

ArticlePLoS neglected tropical diseases2017

Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity.

Stephen R Doyle, Catherine Bourguinat, Hugues C Nana-Djeunga, Jonas A Kengne-Ouafo, Sébastien D S Pion, Jean Bopda, Joseph Kamgno, Samuel Wanji, Hua Che, Annette C Kuesel and 7 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 224 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Article
  15. Procedure for Handling and Storage ofTropical medicine and infectious disease · 2023
    Article
  16. AssessingPathogens (Basel, Switzerland) · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 7 countries.

Stephen R DoyleDepartment of Animal, Plant and Soil Sciences, La Trobe University, Bundoora, Australia.ORCID http://orcid.org/0000-0001-9167-7532
Catherine BourguinatInstitute of Parasitology, McGill University, Sainte Anne-de-Bellevue, Québec, Canada.
Hugues C Nana-DjeungaParasitology and Ecology Laboratory, Department of Animal Biology and Physiology, Faculty of Science, University of Yaoundé 1, Yaoundé, Cameroon.
Jonas A Kengne-OuafoResearch Foundation in Tropical Diseases and the Environment (REFOTDE), Buea, Cameroon.
Sébastien D S PionInstitut de Recherche pour le Développement (IRD), IRD UMI 233 TransVIHMI - Université Montpellier - INSERM U1175, Montpellier, France.
Jean BopdaFaculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon.
Joseph KamgnoCentre for Research on Filariasis and other Tropical Diseases (CRFilMT), Yaoundé, Cameroon.
Samuel WanjiResearch Foundation in Tropical Diseases and the Environment (REFOTDE), Buea, Cameroon.
Hua CheInstitute of Parasitology, McGill University, Sainte Anne-de-Bellevue, Québec, Canada.
Annette C KueselUNICEF/UNDP/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases (WHO/TDR), World Health Organization, Geneva, Switzerland.
Martin WalkerLondon Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, Faculty of Medicine, School of Public Health, Imperial College London, United Kingdom.
Maria-Gloria BasáñezLondon Centre for Neglected Tropical Disease Research, Department of Infectious Disease Epidemiology, Faculty of Medicine, School of Public Health, Imperial College London, United Kingdom.
Daniel A BoakyeNoguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Mike Y Osei-AtweneboanaDepartment of Environmental Biology and Health Water Research Institute, Council for Scientific and Industrial Research (CSIR), Accra, Ghana.
Michel BoussinesqInstitut de Recherche pour le Développement (IRD), IRD UMI 233 TransVIHMI - Université Montpellier - INSERM U1175, Montpellier, France.
Roger K PrichardInstitute of Parasitology, McGill University, Sainte Anne-de-Bellevue, Québec, Canada.
Warwick N GrantDepartment of Animal, Plant and Soil Sciences, La Trobe University, Bundoora, Australia.
McGill University · CAUniversité de Yaoundé I · CMInserm · FRLa Trobe University · AULondon Centre for Neglected Tropical Disease Research · GBCouncil for Scientific and Industrial Research · GHUniversity of Ghana · GHWorld Health Organization · CH

Funding

Wellcome TrustWorld Health Organization 001
6 · The paper itself

Abstract

backgroundTreatment of onchocerciasis using mass ivermectin administration has reduced morbidity and transmission throughout Africa and Central/South America. Mass drug administration is likely to exert selection pressure on parasites, and phenotypic and genetic changes in several Onchocerca volvulus populations from Cameroon and Ghana-exposed to more than a decade of regular ivermectin treatment-have raised concern that sub-optimal responses to ivermectin's anti-fecundity effect are becoming more frequent and may spread. METHODOLOGY/PRINCIPAL

findingsPooled next generation sequencing (Pool-seq) was used to characterise genetic diversity within and between 108 adult female worms differing in ivermectin treatment history and response. Genome-wide analyses revealed genetic variation that significantly differentiated good responder (GR) and sub-optimal responder (SOR) parasites. These variants were not randomly distributed but clustered in ~31 quantitative trait loci (QTLs), with little overlap in putative QTL position and gene content between the two countries. Published candidate ivermectin SOR genes were largely absent in these regions; QTLs differentiating GR and SOR worms were enriched for genes in molecular pathways associated with neurotransmission, development, and stress responses. Finally, single worm genotyping demonstrated that geographic isolation and genetic change over time (in the presence of drug exposure) had a significantly greater role in shaping genetic diversity than the evolution of SOR. CONCLUSIONS/SIGNIFICANCE: This study is one of the first genome-wide association analyses in a parasitic nematode, and provides insight into the genomics of ivermectin response and population structure of O. volvulus. We argue that ivermectin response is a polygenically-determined quantitative trait (QT) whereby identical or related molecular pathways but not necessarily individual genes are likely to determine the extent of ivermectin response in different parasite populations. Furthermore, we propose that genetic drift rather than genetic selection of SOR is the underlying driver of population differentiation, which has significant implications for the emergence and potential spread of SOR within and between these parasite populations.

Indexed as

Drug ResistanceGene Expression ProfilingGenetic DriftAnimalsAntiparasitic AgentsCameroonFemaleGenetic VariationGenotypeGhanaHigh-Throughput Nucleotide SequencingHumansIvermectinOnchocerca volvulusOnchocerciasisQuantitative Trait LociAntiparasitic AgentsIvermectin

Identifiers

PMID28746337
PMCPMC5546710
OpenAlexW2951131794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.